Stockreport

Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF First publicly listed company to actively investigate psilocybin’s potential impact on longevity NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. ( [Read more]